| 10 | TMBRQ bankruptcy effective, 5/9/2024. Common | Steel Reserve | 05/09/2024 10:07:08 PM |
| 9 | $TMBR 110% v19,4M c2.99 f3,044M Hod3.20 PMH3.28 | znewcar1 | 08/21/2023 10:57:56 PM |
| 8 | $TMBR 34% v1,57M c2.36 f2,971M H2.45 ML1.2 | znewcar1 | 01/03/2023 4:33:22 PM |
| 7 | Because it so LOW? Morning dip to LL of.0585 MH.1 | znewcar1 | 11/01/2022 9:27:47 PM |
| 6 | I'm thinking there might be some potential with | SaltyMutt | 11/01/2022 6:11:25 AM |
| 5 | $TMBR Timber Pharmaceuticals is the play of the | EliteStockPicks | 08/29/2022 8:25:40 AM |
| 4 | TMBR 38% v187M c.15 f110M H.1870 | znewcar1 | 08/11/2022 9:39:30 PM |
| 3 | TMBR 23% v6,2M c1.53 f36,8M H1.73 | znewcar1 | 04/21/2021 4:32:26 PM |
| 2 | TMBR 28% v8,7M c2.10 f11,8M bounced off 1.42 | znewcar1 | 02/24/2021 5:08:41 PM |
| 1 | TMBR 30% v22,7M c3.06 f11,8M | znewcar1 | 02/16/2021 5:27:34 PM |
Recent Articles
- BayCare Cancer Institute Unveils Proton Therapy Breakthrough
- XiuShan Mining Enhances Cloud Services for Bitcoin Mining Access
- Exploring Innovative Income Models in Digital Asset Mining
- Lantheus Holdings, Inc. Investors Can Pursue Securities Case
- Visionary Holdings Faces Nasdaq Compliance Challenges Ahead
- Trump's Steady Approval Amid Shutdown and Controversial Renovations
- The Influence of the Best Beaches in Los Angeles on Local Property Prices
- The Power of Female Consumers in Today’s Economy
- Visionary Holdings Inc. Addresses Nasdaq Compliance Notification
- Keystone Resort Kicks Off Winter Season with Exciting Events
- How to Spot a Tech Startup That Is Investment-Ready
- Agadir’s Tourism Upswing: Clear Signals for Investors
- Hormel Foods Initiates Safety Recall for Fire Braised Products
- How to Market Your Pennsylvania Rental Property to Couples and Young Professionals
- SpaceX Creates Ripples in Crypto Market with Massive Bitcoin Move
- How Financial Institutions Are Building Resilience Into Their Lending Portfolios
- Changpeng Zhao's Vision on Crypto's Contribution to Economy
- The ROI of Contractor Education: Is It Worth Paying for Licensing Prep?
- Why Social Media Engagement Metrics Are Quietly Becoming a Financial Valuation Signal for Modern Brands
- RakeBit Shines as a Preferred Choice in No KYC Casinos
- Elevate Your Game with BitStarz: The Top Choice for Plinko Players
- BitStarz: Your Ultimate Guide to No Deposit Casino Bonuses
- Understanding Your Rights with Zions Bancorporation after Losses
- Discover the Revolutionary Cyber Heater for Optimal Home Comfort
- Essential Travel Insurance Insights for Indian Tourists Abroad
- How Small Business Owners Can Achieve Financial Agility in Uncertain Times
- Exploring the Best Online Casinos for Fast Payouts in 2025
- Trump's Diplomatic Approach: Meeting Kim Jong Un Again?
- Kamala Harris Looks Ahead: Potential 2028 Presidential Bid
- Turning Condo Ownership Into a Profitable Long-Term Investment
- How to Find the Perfect New Home in Your Desired Location
- Discover RubyReels: Australia’s Next Top Online Casino in 2025
- DeLeion Capital Seizes Opportunities in Crypto Landscape
- EU Takes Bold Steps to Secure Rare Earth Supply Chain
- What Investors Need to Know About Jasper Therapeutics Class Action
- KBR Investors Urged to Act Ahead of Class Action Deadline
- Trump's Rally in New Jersey: A Clash of Political Titans
- Discover the Excellence of Kratom Bird's Online Shopping Experience
- Avacta Unveils Promising Dual Payload Data from Cancer Therapies
- Exploring the Breakthrough Potential of BBO-10203 in Cancer Treatment
- AlphaTON Capital and Cyncado Therapeutics Advance Cancer Research
- Investor Insights: Key Stocks Sparking Discussions This Week
- Novartis Unveils Promising Results in Autoimmune Research
- Innovative CLN-978 Shows Promise for Autoimmune Treatments
- Innovative Advances in Rare Disease Care Highlighted by Sobi
- Cytokinetics Faces Class Action: What Investors Need to Know
- Innovative B Cell Treatment CLN-978 Shows Promising Data
- Exploring Elon Musk's Vision for a Future with Universal High Income
- The Digital Hotelier's Bold Move into the Americas Market
- BIMZELX® Insights: Three-Year Results in Rheumatology Showcase Progress
